argus

SMS Pharmaceuticals Ltd

NSE: SMSPHARMAINE812G010253,494 Cr

Timeline

Time (IST)TypeMEventSrc
02 Sept, 08:55 amrating_action1CARE Ratings Limited reaffirmed the long-term bank facilities rating at 'CARE A' with a stable outlook (revised from positive) and reaffirmed the short-term bank facilities rating at 'CARE A1'.nse
27 Aug, 11:38 amSMS Pharmaceuticals Limited had intimated the 16-Sep-2026 as the record date. The Company has now informed the Exchange that the Record date has been revised to 22-Sep-2026 for the purpose of DI.nse
27 Aug, 11:29 amSMS Pharmaceuticals Limited has informed the Exchange about change in date of 38th Annual General Meetingnse
06 Aug, 12:55 pmSMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation on tax deduction at source on dividend '.nse
01 Aug, 05:15 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
01 Aug, 05:10 pmSMS Pharmaceuticals Limited has informed the Exchange about Investor Presentationnse
01 Aug, 05:06 pmSMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 01, 2026, titled "Press Release on Financial Results".nse
01 Aug, 05:04 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
31 Jul, 06:05 pmSMS Pharmaceuticals Ltd - 532815 - Announcement Under Regulation 30bse
31 Jul, 06:05 pmSMS Pharmaceuticals Limited has informed the Exchange about General Updatesnse
31 Jul, 05:39 pmSMS Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 16-Sep-2026.nse
31 Jul, 05:35 pmSMS Pharmaceuticals Ltd - 532815 - Fixation Of Record Datebse
31 Jul, 05:33 pmSMS Pharmaceuticals Limited has informed the Exchange about change in Managementnse
31 Jul, 05:31 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Change in Managementbse
31 Jul, 05:26 pmFinancial Resultsnse
31 Jul, 05:20 pmSMS Pharmaceuticals Ltd - 532815 - Financial Results For The Quarter Ended 30Th June, 2026bse
31 Jul, 05:13 pmSMS Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
29 Jul, 12:25 pmSMS Pharmaceuticals Ltd - 532815 - Update on board meetingbse
25 Jul, 03:39 pmSMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended 30Th June, 2026bse
22 Jul, 12:30 pmSMS Pharmaceuticals Ltd - 532815 - Reminder Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)bse
22 Jul, 12:29 pmSMS Pharmaceuticals Limited has informed the Exchange about General Updatesnse
20 Jul, 05:10 pmSMS Pharmaceuticals Ltd - 532815 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.bse
20 Jul, 05:05 pmSMS Pharmaceuticals Limited has informed the Exchange about General Updatesnse
01 Jul, 03:26 pmSMS Pharmaceuticals Ltd - 532815 - Clarification On Volume/Price Movementbse
01 Jul, 02:59 pmSMS Pharmaceuticals Ltd - 532815 - Clarification sought from SMS Pharmaceuticals Ltdbse
01 Jul, 02:50 pmSignificant increase in volume has been observed in SMS Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. SMS Pharmaceuticals Limited has submitted their response.nse
30 Jun, 06:22 pmSignificant increase in volume has been observed in SMS Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.nse
15 Jun, 06:27 pmSMS Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
05 Jun, 03:42 pmSMS Pharmaceuticals Ltd - 532815 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015.bse
05 Jun, 03:36 pmSMS Pharmaceuticals Limited has informed the Exchange about General Updatesnse
30 May, 02:05 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
30 May, 01:03 pmSMS Pharmaceuticals Limited has informed the Exchange about Transcriptnse
27 May, 05:03 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
27 May, 04:52 pmSMS Pharmaceuticals Limited has informed the Exchange about Link of Recordingnse
23 May, 06:17 pmSMS Pharmaceuticals Limited has informed the Exchange about General Updatesnse
23 May, 06:12 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
23 May, 05:49 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
23 May, 05:46 pmSMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 23, 2026, titled "Press Release".nse
22 May, 03:24 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Change in Registered Office Addressbse
22 May, 03:22 pmSMS Pharmaceuticals Limited has informed the Exchange regarding change in Registered Office of the company.nse
22 May, 03:20 pmSMS Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32nse
22 May, 03:19 pmSMS Pharmaceuticals Ltd - 532815 - Statement Of Deviation & Variation For The Quarter Ended 31St March, 2026bse
22 May, 03:15 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Change in Managementbse
22 May, 03:12 pmSMS Pharmaceuticals Limited has informed the Exchange regarding Change in Auditors of the company.nse
22 May, 02:06 pmSMS Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2026, recommended Final Dividend of Rs. 0.40 per equity share.nse
22 May, 02:04 pmSMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Dividend Updatesbse
22 May, 01:59 pmFinancial resultsnse
22 May, 01:56 pmSMS Pharmaceuticals Ltd - 532815 - Financial Results For The 4Th Quarter And Year Ended 31St March, 2026bse
22 May, 01:50 pmSMS Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
16 May, 10:36 amSMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Approval Of Financial Results For The Quarter And Financial Year Ended 31St March, 2026bse